Delivery Order SPE2DR25D3012-SPE2DR26F4C4D
Award Date 11/26/25
Potential Completion Date 11/28/25
Potential Value $6.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $7,821.66 to AmerisourceBergen Drug Corp for MONOVISC 88 mg/4 mL syringes (4 mL quantity) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. MONOVISC is a hyaluronic acid injection used for the treatment of osteoarthritis knee...
- The Defense Logistics Agency awarded a $7,083.15 delivery order to AmerisourceBergen Drug Corp for Monovisc 88 mg/4 mL syringes on October 23, 2025, with an ultimate completion date of October 24, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Monovisc is a hyaluronic acid-based injection used for joint pain management and osteoarthritis treatment, representing a...
- The Defense Logistics Agency awarded a delivery order valued at $3,711.30 to AmerisourceBergen Drug Corp for Monovisc 88 mg/4 mL syringes on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order for pharmaceutical supplies to be performed at the awardee's facility in Conshohocken, Pennsylvania. Monovisc is a hyaluronic acid injection used for joint pain management, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $7,229.88 to AmerisourceBergen Drug Corp for the supply of MONOVISC 88 mg/4 ml syringes on June 17, 2025, with an ultimate completion date of June 18, 2025. This competitive, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. MONOVISC is a hyaluronic acid-based viscosupplement used for osteoarthritis pain management,...
- The Defense Logistics Agency awarded a delivery order valued at $4,233.00 to AmerisourceBergen Drug Corp for Monovisc 88 mg/4 ml syringes on December 19, 2025, with completion targeted for December 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Monovisc is a viscosupplement injection used for osteoarthritis pain management, representing a specialized...
- The Defense Logistics Agency awarded a delivery order valued at $19,860.40 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 ml syringes on a firm fixed-price basis. The order was competitively awarded without set-aside designation and is scheduled for completion by January 6, 2026, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. Monovisc is a viscosupplement injection used in orthopedic and rheumatologic applications for managing joint...
- The Defense Logistics Agency awarded a $17,387.95 delivery order to AmerisourceBergen Drug Corp for Monovisc 88 mg/4 ml syringes on November 24, 2025, with completion scheduled for November 25, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $48,183.79 firm fixed price delivery order to AmerisourceBergen Drug Corp for MONOVISC 88 mg/4 mL syringes on September 17, 2025, with an ultimate completion date of September 18, 2025. This is a non-set-aside competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. MONOVISC is a viscosupplement used primarily for...
- The Defense Logistics Agency awarded a delivery order valued at $1,892.93 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 mL syringes (4 mL quantity) under a firm fixed price contract. The award, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-set-aside competitive procurement with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. Monovisc is a hyaluronic acid-based viscosupplement used for...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of MONOVISC 88 mg/4 ml syringes with a ceiling value of $7,012.26. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The contract is scheduled for ultimate completion by December 22, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. MONOVISC is a...